MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,740,566 | -58.5% | 2,157,665 | +7.6% | 0.00% | -100.0% |
| Q2 2023 | $6,598,693 | -10.7% | 2,005,682 | +11.5% | 0.00% | 0.0% |
| Q1 2023 | $7,393,261 | +73795.7% | 1,798,847 | +5.4% | 0.00% | 0.0% |
| Q4 2022 | $10,005 | -99.9% | 1,707,470 | +3.5% | 0.00% | -50.0% |
| Q3 2022 | $11,154,000 | +53.6% | 1,650,019 | +5.0% | 0.00% | +100.0% |
| Q2 2022 | $7,262,000 | +56.0% | 1,571,940 | +34.7% | 0.00% | 0.0% |
| Q1 2022 | $4,655,000 | -34.2% | 1,166,807 | +2.6% | 0.00% | 0.0% |
| Q4 2021 | $7,072,000 | -29.5% | 1,137,001 | +6.8% | 0.00% | 0.0% |
| Q3 2021 | $10,036,000 | -29.7% | 1,064,335 | +1.2% | 0.00% | -50.0% |
| Q2 2021 | $14,285,000 | -7.8% | 1,051,919 | +9.8% | 0.00% | 0.0% |
| Q1 2021 | $15,501,000 | -32.2% | 958,051 | +11.5% | 0.00% | -50.0% |
| Q4 2020 | $22,865,000 | +48.1% | 859,301 | +3.7% | 0.00% | +33.3% |
| Q3 2020 | $15,435,000 | -13.3% | 828,976 | +8.9% | 0.00% | -25.0% |
| Q2 2020 | $17,813,000 | +476.8% | 761,252 | +43.7% | 0.00% | +300.0% |
| Q1 2020 | $3,088,000 | -49.1% | 529,788 | -49.9% | 0.00% | 0.0% |
| Q4 2019 | $6,064,000 | +692.7% | 1,058,344 | +118.5% | 0.00% | – |
| Q3 2019 | $765,000 | -60.9% | 484,412 | +0.2% | 0.00% | – |
| Q2 2019 | $1,957,000 | +0.7% | 483,216 | +30.7% | 0.00% | -100.0% |
| Q1 2019 | $1,944,000 | +85.9% | 369,661 | +44.1% | 0.00% | – |
| Q4 2018 | $1,046,000 | -14.5% | 256,464 | +109.5% | 0.00% | – |
| Q3 2018 | $1,224,000 | -24.6% | 122,434 | +34.7% | 0.00% | – |
| Q2 2018 | $1,623,000 | +19.4% | 90,909 | +5.4% | 0.00% | – |
| Q1 2018 | $1,359,000 | +31.1% | 86,217 | +36.5% | 0.00% | – |
| Q4 2017 | $1,037,000 | +4.6% | 63,173 | +10.1% | 0.00% | – |
| Q3 2017 | $991,000 | – | 57,352 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |